Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating filgotinib for induction and maintenance of remission in adults with moderately to severely active ulcerative colitis has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Filgotinib (filgotinib)

Snippet

Sponsor: Gilead Sciences | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2021-04-21